Optimization of a transcatheter heart valve frame using patient-specific computer simulation by Rocatello, Giorgia et al.
Optimization of a Transcatheter Heart Valve Frame Using
Patient-Speciﬁc Computer Simulation
GIORGIA ROCATELLO,1 GIANLUCA DE SANTIS,2 SANDER DE BOCK,2 MATTHIEU DE BEULE,2 PATRICK SEGERS,1
and PETER MORTIER2
1IBiTech-bioMMeda, Ghent University, Ghent, Belgium; and 2FEops NV, Technologiepark-Zwijnaarde 122, 9052 Ghent,
Belgium
(Received 15 December 2018; accepted 7 June 2019)
Associate Editor Ajit P. Yoganathan oversaw the review of this article.
Abstract
Purpose—This study proposes a new framework to optimize
the design of a transcatheter aortic valve through patient-
speciﬁc ﬁnite element and ﬂuid dynamics simulation.
Methods—Two geometrical parameters of the frame, the
diameter at ventricular inﬂow and the height of the ﬁrst row
of cells, were examined using the central composite design.
The effect of those parameters on postoperative complica-
tions was investigated by response surface methodology, and
a Nonlinear Programming by Quadratic Lagrangian algo-
rithm was used in the optimization. Optimal and initial
devices were then compared in 12 patients. The comparison
was made in terms of device performance [i.e., reduced
contact pressure on the atrioventricular conduction system
and paravalvular aortic regurgitation (AR)].
Results—Results suggest that large diameters and high cells
favor higher anchoring of the device within the aortic root
reducing the contact pressure and favor a better apposition
of the device to the aortic root preventing AR. Compared to
the initial device, the optimal device resulted in almost
threefold lower predicted contact pressure and limited AR in
all patients.
Conclusions—In conclusion, patient-speciﬁc modelling and
simulation could help to evaluate device performance prior
to the actual ﬁrst-in-human clinical study and, combined
with device optimization, could help to develop better devices
in a shorter period.
Keywords—Computer simulation, Design of experiment,
Optimization, Patient-speciﬁc, Transcatheter aortic valve.
INTRODUCTION
To date, the design and development phase of new
cardiovascular devices is mainly based on benchmark
tests and animal experiments, leading to long iterative
development cycles. However, in the end, it still re-
mains unclear how the ﬁnal device will perform in
diseased human anatomies, resulting in signiﬁcant
risks for the ﬁrst patients that undergo treatment with
a new device, as well as for the manufacturers of these
devices. Using patient-speciﬁc computational mod-
elling and simulation during the design and develop-
ment phase could help to address these challenges.25
This approach allows to assess the interaction between
devices and realistic human anatomies, opening the
door towards in-silico clinical trials that could be
conducted prior to the actual ﬁrst-in-human clinical
study. In this way, risks for patients and manufacturers
can be signiﬁcantly reduced. In addition, combining
patient-speciﬁc computational modelling and simula-
tion with device optimization techniques can help to
develop better devices in a shorter time period.
Many computational modelling and simulation
optimization studies have been performed to ﬁnd
optimal stent geometrical parameters based on
mechanical or ﬂow-related objectives: radial
strength,26,27 fatigue resistance,1,18,19 frame expan-
sion,18,19 ﬂow disturbances and wall shear stress.12,23,28
However, the majority of those studies evaluated solely
unit stent models,1 thereby neglecting the interactions
with the arterial tissues. Others have used three-di-
mensional models12,17,20 and accounted for interac-
tions with simpliﬁed vessel geometries.18,28 Very
recently Bosi et al.5 combined patient-speciﬁc modeling
and optimization techniques to tune the material
parameter of the aortic root in 14 patients, to improve
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simulation results (i.e., prediction of post-implantation
device deformation and paravalvular gaps).
To the best of our knowledge, this is the only
available study that combines patient-speciﬁc mod-
elling and optimization techniques. However, a device
optimization study based on patient-speciﬁc modelling
has not yet been performed. Such approach could be
useful for a wide range of procedures and devices, but
this study focuses on transcatheter aortic valve
implantation (TAVI).
Clinical studies9,14,21 have demonstrated the efﬁcacy
of TAVI to treat patients with aortic stenosis at ex-
treme- and intermediate-risk. However, complications
as paravalvular aortic regurgitation (AR) and con-
duction abnormalities are considered the Achille’s heel
of this treatment. AR has been associated with
increased mortality,7,15,16 whereas conduction abnor-
malities leading to implantation of permanent pace-
maker are associated with increased costs, longer
hospital stays and increased patient’s morbidity.
Considering the prospective of treating younger
patients at low surgical risk, those complications are
inacceptable and need to be addressed by improved
devices and procedures.
To be eﬀective and prevent migration, TAVI devices
need to anchor at or below the annulus of the aortic
root. A good apposition between the device and the
aortic wall plays a key role in avoiding paravalvular
AR. On the other hand, the contact between the stent
and the aortic root might generate high pressure on the
atrioventricular conduction system which, in turn,
might be responsible of conduction abnormalities.
Previous studies have reported that patient-speciﬁc
computer simulation can be used to predict par-
avalvular AR and conduction abnormalities after
implantation of a CoreValve Revalving System
(Medtronic).4,6,8,22,29
In this proof-of-concept study, we propose a
framework to improve geometric parameters of a
representative TAVI device frame through patient-
speciﬁc computer models able to predict post-operative
outcomes.
FIGURE 1. Valve geometry. (a) unwrapped configuration; (b) profile of the frame of a CoreValve 29 mm; (c) unwrapped
configuration with offset; (d) expanded valve configuration, (e) detail of the valve strut. In red the geometrical frame parameters
under investigation: X1 is the diameter at 4 mm above the ventricular inflow, X2 is the height of the first row of cells.
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MATERIALS AND METHODS
Valve Geometry and Material Properties
A parametric model of a 29-mm CoreValve-like
transcatheter aortic valve was created. The base
geometry of the frame was modeled starting from the
planar ‘unwrapped’ conﬁguration in pyFormex (www.
nongnu.org/pyformex). The ‘unwrapped’ frame design
can be seen as a repetition of 15 diamond-like cells
along the circumferential axis and 4 diamond-like cells
along the longitudinal axis (Fig. 1a). Each cell was
described with Cubic Bezier spline interpolation.11 The
proﬁle of the frame of a CoreValve 29 mm (Fig. 1b)
was used to generate an offset of the ‘planar’ frame
(i.e., varying radius) (Fig. 1c). Finally, the planar
frame was ‘wrapped’ to obtain a CoreValve-like shape,
in the expanded conﬁguration (Fig. 1d), by applying a
coordinate transformation to the nodes of the frame.
Geometric parameters of the reference frame design
are summarized in Table 1. Brieﬂy, the frame’s height
was 46.0 mm, the diameter at the ventricular inﬂow
was 29.0 mm and the diameter at the aortic outﬂow
was 38.0 mm. The strut width and thickness (0.25 mm,
0.45 mm) were in line with literature.6,13 The frame
was modeled with Timoshenko beam elements (B31 in
the Abaqus nomenclature) and WELD connectors
were used at the interpolation points between adjacent
cells (Fig. 1e). A mesh sensitivity analysis was per-
formed on the device radial force during the crimping
and expansion phases. The ﬁnal stent mesh counted
2670 elements. The material properties of the Nitinol
alloy were taken from literature24 (Table 2).
Patient-Speciﬁc Aortic Root Model
Three-dimensional aortic root models were retro-
spectively reconstructed from anonymized pre-opera-
tive MSCT images of 12 patients, who underwent
TAVI in two European centers (Rigshospitalet in
Copenhagen, Denmark; Erasmus medical Center in
Rotterdam, The Netherlands). Selected patients (3
males, 9 females), between 74 and 89 years old, were
considered representative of the TAVI population
(e.g., patients with calciﬁed tricuspid or bicuspid aortic
valve, heavy calciﬁed valve or sub-annular calciﬁca-
tions). All patients had comparable annular diameters
ranging from 23.0 to 26.0 mm. More details of the
TABLE 1. Frame reference adopted geometrical parameters.
Parameter Description Value (mm)
H Height 46.0
Din Diameter at ventricular inflow 29.0
Dout Diameter at aortic outflow 38.0
Dostia Diameter at ostia level 23.0
wst Strut width 0.25
thst Strut thickness 0.45
Hskirt Skirt height 13.0
TABLE 2. Nitinol material parameters for modeling the frame
behavior24.
Parameter Description Value
EA Austenite elastic modulus 51.7 MPa
EM Martensite elastic modulus 47.8 MPa
m Poisson’s ratio 0.3
rSL Start of transformation loading 600 MPa
rEL End of transformation loading 670 MPa
rSU Start of transformation unloading 288 MPa
rEU End of transformation unloading 254 MPa
eL Maximum transformation strain 6.3%
eLV Maximum volumetric transformation
strain
6.3%
FIGURE 2. Computer simulation strategy. (a) Patient-specific 3D reconstruction of the aortic root and the region of the
atrioventricular conduction system (in red the 3 anatomical landmarks identified using pre-operative CT images); (b) positioning of
the crimped device within the aortic root; (c) deployment of the device using FE computer simulation; (d) extraction of contact
pressure output within the region of the atrioventricular conduction system; (e) CFD simulation and predicted regurgitant jets.
CT 5 computed tomography. NCC 5 noncoronary cusp. RCC 5 right-coronary cusp.
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selected patients are reported in Table 3. Three-di-
mensional aortic root models consisted of the left-
ventricular outﬂow tract (LVOT), the sinotubular
junction and calciﬁed aortic leaﬂets and ascending
aorta (Fig. 2a). Linear elastic models rather than a
more realistic but complex hyperelastic anisotropic
description were adopted to describe the aortic root
tissues. Modelling parameters were derived in a pre-
vious study31 with an iterative process of back-calcu-
lations using pre and postoperative MSCT of 39
patients. The aortic wall had an elastic modulus of
2 MPa and a uniform thickness of 2 mm. For the
aortic leaﬂets, elastic modulus of 0.6 MPa and uniform
thickness of 1.5 mm was adopted.3,10 Calciﬁcations
were modeled using a stiffer elastic material with per-
fect plasticity (E = 4 MPa, m = 0.3, yield
stress = 0.6 MPa).29,31 Spring elements were added at
each node of the aortic wall to incorporate the impact
of surrounding structures in the model.
In each 3D aortic root model, the region of the
atrioventricular conduction system was identiﬁed as
previously described.29 Brieﬂy, the inferior border of
the membranous septum was identiﬁed in the pre-op-
erative CT images through three dedicated landmarks
(Fig. 2a). Two of these landmarks were selected at the
beginning and at the end of the inferior border of the
membranous septum, namely p1 and p3, with p1 closer
to the non-coronary cusp (NCC) and p3 closer to the
right coronary cusp (RCC). An additional point (p2)
was selected in between to better track the course of
the inferior border of the membranous septum as this
is often not a straight line. Starting from these
anatomical landmarks, the region of the atrioventric-
ular conduction system was deﬁned by the area
between the inferior border of the membranous septum
(extended towards the RCC by a 25 angle) and the
plane 15 mm below the annulus (Fig. 2a). The model
of the patient-speciﬁc anatomy was pre-processed
using TAVIguide (FEops, Gent, Belgium).
Computer Simulation Strategy and Output Variables
Finite-element (FE) simulations were performed
using Abaqus/Explicit (v2017, Dassault Systemes
Simulia Corp, Johnson, RI). The computer simulation
strategy can be subdivided in three steps. In the ﬁrst
step, the device was crimped into the catheter (6 mm
diameter), using a cylindrical surface.
In the second step, the device was positioned coax-
ially within the aortic root (Fig. 2b), and the catheter
was retracted leading to the expansion of the device.
The default general contact with ﬁnite sliding between
all the surfaces was used, assuming a coefﬁcient of
friction of 0.7 between the valve frame and the aortic
model. In all patients, the device was implanted at
approximately 4 mm below the aortic annulus
(Fig. 2c). In order to evaluate the risk of occurrence of
new conduction abnormalities, the maximum contact
pressure and the contact pressure index (i.e., the per-
centage of this region of interest subjected to contact
pressure) within the region of the atrioventricular
conduction system were extracted (Fig. 2d). The con-
tact pressure index was calculated according to the
following formula:
AreaROI where CP>0ð Þ
AreaROI
 100; ð1Þ
where ROI is the region of interest for the atrioven-
tricular conduction system and CP is the contact
pressure.
As third step, a static computational ﬂuid-dynamics
(CFD) simulation was performed using the ico-FOAM
TABLE 3. Patients selected for the study.
Patient Age at TAVI Gender Received device (size) Post-TAVIParavalvular AR Post-TAVIConduction abnormalities
1 79 M Evolut R (29) Mild –
2 89 F Evolut R (29) Mild --
3 76 M Evolut R (29) Trace --
4 86 F Evolut R (29) Mild --
5 78 M Evolut R (29) Mild to moderate --
6 77 F CoreValve (29) Mild to moderate --
7 88 F CoreValve (29) Mild to moderate Total AVB
8 77 F CoreValve (29) Trace LBBB
9 80 F CoreValve (29) Mild LBBB
10 84 F CoreValve (29) Trace LBBB
11 74 F Lotus (25) None –
12 – F Lotus (23) None –
The ‘received device’ column refers to the device that was implanted in each patient during TAVI. The last two columns report clinical
outcomes in form of paravalvular AR and conduction abnormalities.
‘–’ No conduction abnormalities occurred after TAVI. AR = Aortic regurgitation. TAVI = Transcatheter aortic valve implantation.
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solver available in OpenFOAM (OpenFOAM, v2.1.1,
OpenCFD Ltd., Bracknell, UK). Ico-FOAM is a
transient solver for laminar ﬂow. Brieﬂy, the deformed
geometries (aortic root and device) were extracted
from the FE analysis and a skirt was added to the
TAVI device. The ﬂuid domain was extended with
cylindrical ﬂow extensions of 8 diameters at the inlet
(aortic side) and 3 diameters at the outlet (ventricular
side). The extended ﬂow domain was discretized using
hexahedral elements and reﬁned within the region of
interest (i.e., the lumen within the rigid aortic root
wall). The blood was modeled as Newtonian ﬂuid
(q = 1060 kg/m3, l = 3.5 9 103 Pa s). No slip con-
dition was described at the aortic wall. A ﬁxed
transaortic pressure difference of 32 mmHg was im-
posed to calculate the inlet ﬂow and the location and
the velocity of regurgitant jets (Fig. 2e). The imposed
pressure difference value is the average of the post-
operative end-diastolic transaortic pressure difference
retrospectively observed in a sample of 20 patients.8
This value is in line with the post-operative end-dias-
tolic transaortic pressure difference observed by Sin-
ning et al.32 in a cohort of 146 patients
(33.8 ± 12.3 mmHg). This analysis was previously
validated for prediction of paravalvular AR after
implantation of a CoreValve System.8
Results from ﬁnite-element and ﬂuid-dynamics
simulations were post-processed using the TAVIguide
software.
TABLE 4. Tested levels of experimental variables X1 and X2 in the initial design space.
Parameter
Initial coded levels of variables
 a  1 0 + 1 + a
Valve diameter at 4 mm above the ventricular inflow (mm)
X1 24.9 26.1 29.0 31.9 33.1
Height of the first row of cells at the ventricular inflow (mm)
X2 5.7 6.4 8.0 9.6 10.3
FIGURE 3. Frame designs obtained with the experimental variables X1 and X2 from the initial design space. Geometrical
parameters X1 and X2 are represented in red.
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Experimental Design
The central composite design (CCD) was applied to
determine the best combination of the frame parame-
ters to reduce conduction abnormalities and par-
avalvular AR after TAVI. Given the fact that the
inﬂow portion of the device frame plays a crucial role
in the anchoring and apposition to the aortic root as
well as in the above-mentioned clinical outcomes, we
selected two geometrical parameters in this region of
the frame. These two parameters are: the valve diam-
eter at 4 mm above the ventricular inﬂow (X1, mm)
and the height of the ﬁrst row of cells at the ventricular
inﬂow (X2, mm) (Fig. 1b). Initial value for X1 is
29.0 mm and for X2 is 8.0 mm. The initial design space
was limited by X1 ± 10% and X2 ± 20%. The
parameter levels are coded as  a (low axial level),  1
(low level), 0 (central point), + 1 (high level) and + a
(high axial level), with a equals
ﬃﬃﬃ
2
p
. Independent vari-
ables and their levels for the CCD used in the initial
design space are shown in Table 4. The designs of the
frame obtained with the different combination of the
geometrical parameters (X1 and X2) based on the initial
design space are shown in Fig. 3. A qualitative analysis
of the effects of the two parameters on the outputs
showed that high X1 and X2 parameters were associ-
ated with low values of the outputs. Detailed results
obtained from the analysis in the initial design space
can be found in Online Appendix 1. Based on the ef-
fects of the two selected geometrical frame parameters
on the outputs, subsequent reﬁnement of the design
space was performed. Independent variables and their
levels for the CCD used in the reﬁned design space are
shown in Table 5.
Response Surface Methodology
A second-order polynomial response surface model
(RSM) was used to ﬁt the predicted outputs that are
the maximum contact pressure and the contact pres-
sure index (FE outputs) and the paravalvular AR
(CFD output). As the study aim was to minimize the
outputs predicted from the implantation of each device
in all patients, their value averaged over all patients
was considered. The ﬁtting was based on the mini-
mization of the residual error measured by sum of
squared deviations between the actual and the esti-
mated response. The second-order polynomial equa-
tion has been assumed as:
Y ¼ B0 þ
X
2
i¼1
BiXi þ
X
2
i¼1
BiiX
2
i þ
X
2
i<j
BijXiXj  er ð2Þ
with Y the value of one output parameter averaged
over the 12 patients, B the coefﬁcients, X the experi-
mental variables and er the error associated with the
model. Only the most signiﬁcant terms from the
polynomial equation were selected using the Exhaus-
tive Search method.
The quality of the model was assessed by coeﬃcients
of determination: R2, adjusted R2, predicted R2, and
residuals. R2 represents a pure correlation between
measured and predicted values and is indicative of the
response variation explained by the model. Adjusted R2
is used to compare the explanatory power of the
model, and its value increases only if an added term
improves the model. The predicted R2 assesses the
predictive power of the model for new observations.
This coefﬁcient was calculated by systematically
removing each observation from the data set, esti-
mating the regression equation and determining how
well the model predicted the removed observation.2
Residual plots present the difference between the ac-
tual and the predicted values and were used to assess
whether the coefﬁcients predictions were biased. All
analyses were performed in Isight (Dassault Systemes
Simulia Corp, Johnson, RI).
Optimization Strategy
The Nonlinear Programming by Quadratic La-
grangian (NLPQL) was adopted as optimization
algorithm, under the assumption that the objective
functions are continuously diﬀerentiable.30 The three
objective functions were rescaled to have a value
between 0 and 1 (Eq. (3)) and combined into a single-
objective function using a weighted sum method
(Eq. (4)):
TABLE 5. Tested levels of experimental variables X1 and X2 in the refined design space.
Parameter
Initial coded levels of variables
 a  1 0 + 1 + a
Valve diameter at 4 mm above the ventricular inflow (mm)
X1 28.4 29.0 30.5 31.9 32.5
Height of the first row of cells at the ventricular inflow (mm)
X2 7.7 8.0 8.8 9.6 9.9
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yi ¼ xi
maxðxÞ ð3Þ
X
3
i¼1
wiOi X1;X2ð Þ ð4Þ
In Eq. (3) xi is a value of one output and yi is the
corresponding rescaled value.
In Eq. (4), wi is the weight of each objective and Oi
are the objectives (RSM functions). In this study, the
single-objective function built to minimize the maxi-
mum contact pressure (O1), the contact pressure index
(O2) and the paravalvular AR (O3) was:
0:5O1 X1;X2ð Þ þ 0:5O2 X1;X2ð Þ þ 1:0O3 X1;X2ð Þ ð5Þ
The weight factors accounted for the fact that
maximum contact pressure (O1) and contact pressure
index (O2) are both predictors of new conduction
abnormalities.
Lastly, the performance of the device with the
optimal parameters was compared with the perfor-
mance of the initial device in each patient. The one-
tailed Wilcoxon rank test in SPSS (version 22.0, IBM
Corporation, New York) was performed to verify
whether the improvement in the predicted outcomes
was statistically signiﬁcant. The predicted maximum
contact pressure, contact pressure index and par-
avalvular AR are reported as mean (standard devia-
tion).
Figure 4 summarizes the workﬂow of the method
used in this study.
RESULTS
In total, 16 devices were created in this study: 9
devices based on the initial design space and 7 addi-
tional ones based on the reﬁned design space. Each
device was implanted in 12 patients (FE simulation)
and, subsequently, a CFD simulation was performed
for each patient to derive the paravalvular AR (Fig. 4).
Therefore, this study counted 192 FE simulations and
same amount of CFD simulations.
Average time for FE simulation was 53 min on a
cluster with 16 computing cores (@ 4.0 GHz and
63.0 GB RAM for each node). All CFD simulations
were performed on 2 cores (@ 3.2 GHz and 15.2 GB
RAM for each node). Average time was 3 h and
50 min.
Goodness of Fit
The CCD was used to provide good ﬁtting with a
second-order polynomial function. RSM polynomial
models for maximum contact pressure (O1), contact
pressure index (O2) and paravalvular AR (O3) are
respectively:
O1 ¼ 3:57 0:08X1  0:01X22
O2 ¼ 70:38 3:92X2  0:02X21
O2 ¼ 0:23þ 4:15X2  0:11X1X2
The coeﬃcient of determination R2, adjusted R2 and
predicted R2 of the models are reported in Table 6.
The coeﬃcient of determination R2 for all models
was higher than 0.89, which indicates a good approx-
imation of the actual function at the design points used
for its construction (Fig. 5a). The predicted R2 [0.74–
0.86] was in reasonable agreement with the adjusted R2
TABLE 6. Quality of the RSM models.
RSM models R2 Adjusted R2 Predicted R2
O1 0.92 0.89 0.81
O2 0.94 0.93 0.86
O3 0.89 0.86 0.74
FIGURE 4. Pipeline that has been followed in this study.
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[0.86–0.93], indicating good predictive power of the
model. Residual plots (Fig. 5b) indicated that the
coefﬁcients prediction was not biased.
The models have high R2, adjusted R2, predicted R2
and random distribution of residual errors. These
results indicate a good ﬁt of the experimental data and
high precision in predicting maximum contact pres-
sure, contact pressure index and paravalvular AR.
Therefore, the polynomial models were used for fur-
ther analysis.
FIGURE 5. (a) Plot of the actual and predicted responses and (b) of the actual and residual errors at each design point (black
dots). Residuals are defined as the difference between the actual and the predicted responses.
FIGURE 6. Contour plot of the response surface models of the maximum contact pressure, contact pressure index and
paravalvular AR, respectively from the left to the right. AR 5 aortic regurgitation.
BIOMEDICAL
ENGINEERING 
SOCIETY
ROCATELLO et al.
Eﬀects of the Geometrical Parameters
Two-dimensional contour plots of the RSM models
are shown in Fig. 6. High values of maximum contact
pressure were observed for low X1 and X2. The diam-
eter at the ventricular inﬂow of the device (X1) inﬂu-
ences its proﬁle. Small diameters determine a sharp
proﬁle of the frame, while large diameters make the
proﬁle rounder (Fig. 7a). Therefore, small diameters
are associated with local spots of contact with high
maximum contact pressure. In addition, short cells
(X2) at the ventricular inﬂow of the frame increase the
radial force, contributing to high maximum contact
pressure on the aortic wall at the region of the ven-
tricular inﬂow of the device.
The RSM model of the contact pressure index
showed a comparable behavior as for the maximum
contact pressure. High values of contact pressure in-
dex were observed for low X1 and X2. The diameter
(X1) and, therefore, the proﬁle of the frame, strongly
inﬂuences the level at which the device anchors to the
aortic annular region. Large diameters (round proﬁle)
favor a higher anchoring level compared to small
diameters (sharp proﬁle). As the contact pressure in-
dex is a measure of the area of contact between the
device and the aortic wall within the region of the
atrioventricular conduction system, large diameters
(high anchoring level) reduce the area of contact and
are associated with low values of contact pressure
index. On the contrary, the devices with small diam-
eter (sharp proﬁle) often anchor at the level of the
atrioventricular conduction system, resulting in high
contact pressure index value (Fig. 7a). Also, short
cells (X2), associated with higher radial force, favor
the expansion of the frame, contributing to an in-
crease in contact and, hence, the contact pressure
index.
With respect to the paravalvular AR, large diame-
ters (X1) and short cells (X2) favor a better apposition
of the device to the aortic root, reducing paravalvular
AR (Fig. 7b). However, the diameter seems to have a
larger inﬂuence on the output compared to the height
of the cells.
FIGURE 7. Representative examples of the effect of the geometrical parameters on maximum contact pressure and contact
pressure index (a), and paravalvular AR (b). At the top, a schematic representation of the CCD. (a) A device with low X1 and low X2
(A) results in high maximum contact pressure and contact pressure index. Whereas, a device with high X1 and X2 (B) results in low
contact within the region of the atrioventricular conduction system. (b) A device with low X1 (C) results in high paravalvular AR,
whereas high X1 (D) prevents paravalvular AR. AR 5 aortic regurgitation. CCD 5 central composite design.
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Optimization Results
Figure 8 reports the optimization history with
NLPQL algorithm for the three objectives O1, O2, O3.
The orange line indicates the position where the min-
imum is located (# Run 13). The starting point corre-
sponds to the initial design parameters: X1 = 29.0 mm
and X2 = 8.0 mm. The optimal parameters are:
X1 = 31.9 mm and X2 = 9.6 mm. The optimized de-
vice is shown in Fig. 9.
Figure 10 reports the maximum contact pressure,
contact pressure index and paravalvular AR obtained
in each patient after implantation of the device with
the initial and the optimized design.
The optimized device was associated with lower
maximum contact pressure and contact pressure index
in all patients. The mean value of maximum contact
pressure associated with the optimized device was al-
most threefold lower compared to the initial device
(0.33 vs. 0.88 MPa). Similarly, the mean value of
contact pressure index was twofold lower (10% vs.
19%). The standard deviation slightly decreased as
well with the optimized device. With regard to par-
avalvular AR, the average value decreased from 6.9 to
4.9 ml/s with the optimized device. Although in some
patients paravalvular AR slightly increased with the
optimized device, the Wilcoxon rank test conﬁrmed
that improvement in maximum contact pressure, con-
tact pressure index as well as paravalvular AR is sta-
tistically signiﬁcant (p value was found £ 0.001 and
£ 0.05 for the contact pressure-related parameters and
for AR respectively).
DISCUSSION
This proof-of-concept study presents an optimiza-
tion workﬂow based on patient-speciﬁc computer
simulation to improve the TAVI device performance in
reducing the predicted paravalvular AR and conduc-
tion abnormalities after TAVI. The central composite
design along with the NLPQL algorithm were adopted
to optimize two geometrical parameters of a Cor-
eValve-like device: the diameter at 4 mm above the
ventricular inﬂow and the height of the ﬁrst row of
cells. The eﬀect of the design parameters on the
objectives was studied using RSM. Results suggest that
large diameters and high height of the ﬁrst row of cells
favor a better apposition of the device to the aortic
wall avoiding paravalvular AR, and lead to an
anchoring level above the location of the atrioven-
tricular conduction system preventing conduction
abnormalities. The optimized device showed improved
performance in all patients. Maximum contact pres-
sure and contact pressure index that are predictive for
FIGURE 8. Optimization history of the objectives-function.
The location of the minimum is indicated by the orange line.
FIGURE 9. Optimal frame design.
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conduction abnormalities lowered with the optimized
device. Predicted paravalvular AR was also reduced in
83% of the patients (10/12). Furthermore, good
improvement in the design was achieved with only
small changes to the geometry which will not change
the mechanics or add diﬃculties in manufacturing.
Most of the existing optimization studies applied to
stent geometries, employed computer simulation to
improve mechanical properties (stress distribution,
radial strength, fatigue resistance) or hemodynamic
properties (ﬂow disturbances, wall shear stress).
However, optimization was based on mechanical tests
performed on solely unit stent models,1 or simpliﬁed
3D stent models12,17,20 neglecting the interaction with
the arterial tissues. Recently, Putra et al.28 adopted
computational ﬂuid dynamics simulation to optimize a
simpliﬁed and idealized two-dimensional stent geome-
try under the inﬂuence of the vessel wall deformation.
Li et al.18 accounted for the interaction of the stent
with simpliﬁed plaque and artery in the optimization of
a stent life prediction and stent expansion. Recently,
Bosi et al.,5 combined patient-speciﬁc modeling with
optimization techniques to tune the material parameter
of the aortic root in their TAVI simulation workﬂow.
Though, to the best of our knowledge, this is the ﬁrst
study that adopts full three-dimensional patient-speciﬁc
models to optimize stent geometrical parameters of a
TAVI device, minimizing the predicted clinical compli-
cations in the average population. With this approach,
the performance of the device can be evaluated in
models resembling anatomical variability among
patients eligible for TAVI, (aortic root variability,
amount and location of calciﬁcations, tricuspid or
bicuspid aortic valve) before entering the clinical phase.
This proof-of-concept study shows that computer
simulations based on patient-speciﬁc anatomies and
population-based parameters on a representative
TAVI population can be used to optimize the design of
a TAVI device reducing the costs and the time of the
design and development phase of a new device, as well
as the level of risk during the clinical studies.
This is a valuable approach with the potential to be
extended to medical devices in general. The objectives
can also be extended to any other clinical outcome as
long as computational modelling and simulation can
accurately predict those outcomes. In this study, the
optimized device is quite similar to the CoreValve
system, for which the strategy for predicting par-
avalvular AR and conduction abnormalities was pre-
viously validated.8,29,31 Due to the similarity between
the CoreValve and the device variants modelled in this
study, we believe the previous validation work remains
valid for these new devices.
While in this study we focused on three key func-
tional post-deployment variables (maximum contact
pressure, contact pressure area and paravalvular
regurgitation), this approach can be used to optimize
any geometrical parameter that plays a relevant role in
the performance of the device (i.e., stress distribution,
durability of the device). Also, the amount of geo-
metrical parameters under investigation can be
increased.
STUDY LIMITATIONS
Although device optimization based on patient-
speciﬁc computer simulation has many advantages in
the stent design, this study has certain limitations.
First, signiﬁcant computational resources are required
to perform this kind of study. A total of 16 devices
were created and virtually implanted in 12 patients,
resulting in 192 FEA simulations and same amount of
CFD simulations. Additionally, iterative repositioning
FIGURE 10. Comparison of performance between the optimized and initial designs. Continuous grey lines represent a decrease
in maximum contact pressure, contact pressure index or paravalvular AR in the same patient. Dotted grey lines represent an
increase in maximum contact pressure, contact pressure index or paravalvular AR in the same patient. Mean (standard deviation)
are represented by the red dot and the blue bar respectively.
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of the device was necessary in some cases, to reach
comparable implantation depth of the device in each
patient. In fact, the obtained optimal device is implan-
tation depth-speciﬁc. Whether it remains the optimal
solution at diﬀerent implantation depths needs to be
veriﬁed. Second, a limited number of patients was en-
rolled in the study. Despite the fact that only 12 patients
were used, they were representative of the population
eligible for TAVI, and assumed suﬃcient for a proof-of-
concept study. In future, automatization of the entire
process is planned, with inclusion of more patients to
ensure optimal device performance. Last, this study
focused on the prediction of three post-procedural
outcomes, but other parameters that play an important
role in the performance and durability of the device
should be evaluated. For example, the crimping feasi-
bility of those devices should be checked to ensure that
the device is not damaged. A mechanical analysis of the
stress distribution on the device frame and device leaf-
lets should be performed to guarantee high performance
and device durability. Also, mechanical factors that
might aﬀect the stress/strain distribution on the aortic
wall to avoid negative outcomes (i.e., annulus rupture)
should be included in the optimization study.
CONCLUSION
In this study, we proposed a framework to improve
the design of a representative TAVI frame using pa-
tient-speciﬁc computer models able to predict post-
operative outcomes. Results show that this approach
can eﬀectively evaluate and optimize the performance
of a TAVI device on a virtual TAVI population. The
proposed approach can help to speed up the initial
design and development phase of new devices and
lower the risk during clinical studies.
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